Scolaris Content Display Scolaris Content Display

Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion

Esta versión no es la más reciente

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

The aim of this review is to investigate the effectiveness and safety of anti‐vascular endothelial growth factor (VEGF) agents for the treatment of macular oedema (MO) secondary to branch retinal vein occlusion (BRVO).